Fintel reports that on November 25, 2024, TD Cowen downgraded their outlook for Despegar.com (NYSE:DESP) from Buy to Sell.

Fintel reports that on November 25, 2024, TD Cowen upgraded their outlook for Sally Beauty Holdings (NYSE:SBH) from Hold to ...

Life Science Tools and Diagnostics stocks are viewed favorably at TD Cowen despite concerns over Trump's policies and his HHS ...

TD Cowen analyst Derrick Wood maintained a Buy rating on Microsoft (MSFT – Research Report) today and set a price target of $475.00. The ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

On Friday, Xylem Inc (XYL) stock saw a modest uptick, ending the day at $121.78 which represents a slight increase of $0.15 or 0.12% from the prior close of $121.63. The stock opened at $121.73 and ...

As reported by the Globe and Mail, TD analyst David Kwan November 22 launched coverage of VHI with a “Buy” rating and a ...

On November 7, TD Cowen raised the price target on Arm to $165 from $150 and kept a Buy rating on the shares. The advisory said Licensing upside drove the Sep 2024 quarter beat and F4Q25 weighted ...

Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...

As previously reported, TD Cowen analyst Mario Mendonca upgraded Scotiabank (BNS) to Buy from Hold with an C$80 price target The firm, which believes ROE is “among the most important financial ...

As previously reported, TD Cowen downgraded GCM Grosvenor (GCMG) to Hold from Buy with a price target of $12.50, down from $13.50. The firm moves to the sidelines citing the combination of strong ...